Randomized, Comparative, Double-Blind, Placebo-Controlled, Triple-Dummy, Study to Investigate Abuse Potential ofof Brivaracetam in Healthy Subjects.

Trial Profile

Randomized, Comparative, Double-Blind, Placebo-Controlled, Triple-Dummy, Study to Investigate Abuse Potential ofof Brivaracetam in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 May 2017

At a glance

  • Drugs Brivaracetam (Primary) ; Alprazolam; Levetiracetam
  • Indications Epilepsy; Seizures
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 May 2017 New trial record
    • 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top